Long-term follow-up after bronchoscopic lung volume reduction valve treatment for emphysema.

ABSTRACT:

Background

Multiple studies have shown that patients with severe emphysema can significantly benefit from bronchoscopic lung volume reduction endobronchial valve (EBV) treatment up to 1 year after treatment. However, hardly any data exist on longer term follow-up, especially on quality of life. Our aim was to investigate long-term follow-up after EBV treatment up to 3 years including quality of life in a real-life routine clinical setting.

Methods

We retrospectively included patients who underwent EBV treatment in our hospital in the Netherlands at least 3 years prior. Patients were invited for annual visits to our hospital, and spirometry, body plethysmography, 6-min walk distance (6MWD) test and St George's Respiratory Questionnaire (SGRQ) were performed during these visit

SUBMITTER: Hartman JE 

PROVIDER: S-EPMC9677246 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature